OMass Therapeutics
OMass Therapeutics develops small-molecule medicines for endocrine and immune diseases using a platform that measures drug targets in their biological surroundings.
$310MSeries C
ParticipantJL
Jefferson Life Sciences
Activity from announced rounds
All recorded activity
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $428.5M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in all activityDraig Therapeutics
Draig Therapeutics develops neuropsychiatric medicines.
$65MSeries B
Role not disclosedFesariusTherapeutics
Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery
$20MSeries A
Role not disclosedJuvena Therapeutics
Develops regenerative biologics to restore tissue function
$33.5MSeries B
Role not disclosed